Literature DB >> 24615447

Institutional animal care and use committee considerations for animal models of peripheral neuropathy.

Thea Brabb, Larry Carbone, Jessica Snyder, Nona Phillips.   

Abstract

Peripheral neuropathy and neuropathic pain are debilitating, life-altering conditions that affect a significant proportion of the human population. Animal models, used to study basic disease mechanisms and treatment modalities, are diverse and provide many challenges for institutional animal care and use committee (IACUC) review and postapproval monitoring. Items to consider include regulatory and ethical imperatives in animal models that may be designed to study pain, the basic mechanism of neurodegeneration, and different disease processes for which neuropathic pain is a side effect. Neuropathic pain can be difficult to detect or quantify in many models, and pain management is often unsuccessful in both humans and animals, inspiring the need for more research. Design of humane endpoints requires clear communication of potential adverse outcomes and solutions. Communication with the IACUC, researchers, and veterinary staff is also key for successful postapproval monitoring of these challenging models.

Entities:  

Keywords:  animal model; endpoints; ethics; institutional animal care and use committee (IACUC); neuropathic pain; peripheral neuropathy; postapproval monitoring; regulations

Mesh:

Substances:

Year:  2014        PMID: 24615447      PMCID: PMC4383225          DOI: 10.1093/ilar/ilt045

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  55 in total

Review 1.  Diagnosis and management of urinary retention.

Authors:  I F Lane
Journal:  Vet Clin North Am Small Anim Pract       Date:  2000-01       Impact factor: 2.093

Review 2.  Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy.

Authors:  A Bierhaus; P P Nawroth
Journal:  Exp Clin Endocrinol Diabetes       Date:  2012-03-08       Impact factor: 2.949

3.  Medication and treatment use in primary care patients with chronic pain of predominantly neuropathic origin.

Authors:  Nicola Torrance; Blair H Smith; Margaret C Watson; Michael I Bennett
Journal:  Fam Pract       Date:  2007-08-01       Impact factor: 2.267

Review 4.  Translation of drug effects from experimental models of neuropathic pain and analgesia to humans.

Authors:  Amit Taneja; Vincenzo Luca Di Iorio; Meindert Danhof; Oscar Della Pasqua
Journal:  Drug Discov Today       Date:  2012-03-03       Impact factor: 7.851

5.  Neuropathic pain following partial nerve injury in rats is suppressed by dietary soy.

Authors:  Y Shir; A Ratner; S N Raja; J N Campbell; Z Seltzer
Journal:  Neurosci Lett       Date:  1998-01-09       Impact factor: 3.046

Review 6.  Chronic neuropathic pain in veterinary patients.

Authors:  Tamara Grubb
Journal:  Top Companion Anim Med       Date:  2010-02

Review 7.  Acquired canine peripheral neuropathies.

Authors:  Paul A Cuddon
Journal:  Vet Clin North Am Small Anim Pract       Date:  2002-01       Impact factor: 2.093

Review 8.  New therapy for neuropathic pain.

Authors:  Hirokazu Mizoguchi; Chizuko Watanabe; Akihiko Yonezawa; Shinobu Sakurada
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 9.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Vincristine-induced peripheral neuropathy in a dog.

Authors:  T A Hamilton; J R Cook; K G Braund; W B Morrison; J R Mehta
Journal:  J Am Vet Med Assoc       Date:  1991-02-15       Impact factor: 1.936

View more
  4 in total

Review 1.  To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.

Authors:  Norman C Peterson; Elizabeth A Nunamaker; Patricia V Turner
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

2.  Identifying and Implementing Endpoints for Geriatric Mice.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

Review 3.  Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.

Authors:  Jordi Bruna; Paola Alberti; Aina Calls-Cobos; Martial Caillaud; M Imad Damaj; Xavier Navarro
Journal:  Exp Neurol       Date:  2019-12-15       Impact factor: 5.330

4.  The refined biomimetic NeuroDigm GEL™ model of neuropathic pain in a mature rat.

Authors:  Mary R Hannaman; Douglas A Fitts; Rose M Doss; David E Weinstein; Joseph L Bryant
Journal:  F1000Res       Date:  2016-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.